Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer

Breast

Volumn 22, Issue 5, 2013, Pages 1001-1004

  van den Hurk, C J G ^a   van de Poll Franse, L V ^a,b   Breed, W P M ^a   Coebergh, J W W ^a   Nortier, J W R ^c  

^a The Netherlands   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Safety; Scalp cooling; Scalp skin metastases

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAXANE DERIVATIVE; THIOTEPA;

ALOPECIA; ARTICLE; AUTOPSY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CELL DAMAGE; COOLING; CYTOTOXICITY; GERMANY; HAIR CELL; HAIR ROOT; HUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN METASTASIS;

SAFETY; SCALP COOLING; SCALP SKIN METASTASES;

ALOPECIA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CRYOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; SCALP; SKIN NEOPLASMS;

EID: 84884161148     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.07.039     Document Type: Article

References (45)

1. Grevelman E.G., Breed W.P. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 2005, 16:352-358.
2. Hurk van den C.J.G., Peerbooms M., Komen M., Nortier J.W.R., Smorenburg C.H., Breed W.P.M. Multicenter results of scalp cooling to prevent chemotherapy-induced alopecia in 1500 breast cancer patients. Suppl Cancer Res 2011, 71:594s. 1s-653s.
3. Lookingbill D.P., Spangler N., Helm K.F. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. JAm Acad Dermatol 1993, 29:228-236.
4. Hu S.C., Chen G.S., Wu C.S., Chai C.Y., Chen W.T., Lan C.C. Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. JAm Acad Dermatol 2009, 60:379-387.
5. Manders K., van de Poll-Franse L.V., Creemers G.J., et al. Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer 2006, 6:179.
6. Hurk van den C.J.G., Eckel R., Poll van de-Franse L.V., et al. Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry. Breast Cancer Res Treat 2011, 128:795-805.
7. Abrams H.L., Spiro R., Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950, 3:74-85.
8. Spencer P.S., Helm T.N. Skin metastases in cancer patients. Cutis 1987, 39:119-121.
9. Enticknap J.B. An analysis of 1,000 cases of cancer with special reference to metastasis. Guys Hosp Rep 1952, 101:273-279.
10. Lee Y.T. Breast carcinoma: pattern of metastasis at autopsy. JSurg Oncol 1983, 23:175-180.
11. Lookingbill D.P., Spangler N., Sexton F.M. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. JAm Acad Dermatol 1990, 22:19-26.
12. Brownstein M.H., Helwig E.B. Metastatic tumors of the skin. Cancer 1972, 29:1298-1307.
13. Schwartz R.A. Cutaneous metastatic disease. JAm Acad Dermatol 1995, 33:161-182. quiz 183-6.
14. Carson H.J., Pellettiere E.V., Lack E. Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma. JCutan Pathol 1994, 21:67-70.
15. Pivot X., Asmar L., Hortobagyi G.N., Theriault R., Pastorini F., Buzdar A. Aretrospective study of first indicators of breast cancer recurrence. Oncology 2000, 58:185-190.
16. Dean J.C. Prevention of doxorubicin-induced hair loss. NEngl J Med 1980, 302:921.
17. Gates O. Cutaneouos metastases of malignant disease. Am J Cancer 1937, 30:718-730.
18. Krathen R.A., Orengo I.F., Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J 2003, 96:164-167.
19. Spaeth D., Luporsi E., Weber B., et al. Efficacy and safety of cooling helmets (CH) for the prevention of chemotherapy-induced alopecia (CIA): a prospective study of 911 patients (pts). JClin Oncol 2008, 26.
20. Sande van de M.A.E., Hurk van den C.J.G., Breed W.P.M., Nortier J.W.R. Hoofdhuidmetastasen bij hoogrisico borstkankerpatienten. Ned Tijdschr Geneeskd 2010, 154:A2134.
21. Dean J.C., Griffith S., Cetas T.C., Mackel C.L., Jones S.E., Salmon S.E. Scalp hypothermia: a comparison of ice packs and the kold kap in the prevention of doxorubicin-induced alopecia. JCO 1983, 1:33-37.
22. Lemieux J., Amireault C., Provencher L., Maunsell E. Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling. Breast Cancer Res Treat 2009, 118:547-552.
23. Janssen F.E. Modelling physiological and biochemical aspects of scalp cooling 2007, Technical University Eindhoven, Eindhoven, MSc Thesis.
24. Hurk van den C.J.G., Breed W.P.M., Mols F. Chemotherapy-induced hair loss. Handbook of hair in health and disease 2012, 403-416. Wageningen Academic Publishers, Wageningen, The Netherlands. P. Ve (Ed.).
25. Komen M., Smorenburg C.H., Breed W.P.M., Van den Hurk C.J.G., Nortier J.W. Evaluation of a trichometer to quantify the prevention of hair loss by scalp cooling during chemotherapy 2011, Poster 546, ECCO, Stockholm.
26. Christodoulou C., Tsakalos G., Galani E., Skarlos D.V. Scalp metastases and scalpcooling for chemotherapy-induced alopecia prevention. Ann Oncol 2006, 17:350.
27. Satterwhite B., Zimm S. The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer 1984, 54:34-37.
28. Lemieux J., Desbiens C., Hogue J.C. Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up. Breast Cancer Res Treat 2011, 128:563-566.
29. Breed W.P.M., Hurk van den C.J.G., Peerbooms M. Presentation, impact and prevention of chemotherapy-induced hair loss; scalp cooling potentials and limitations. Expert Rev Dermatol 2011, 6:109-125.
30. Hurk van den C.J.G., Gerrits P., Graat J., Kolen B., Laar van de- Müskens J., Breed W.P.M. Positieve ervaringen met hoofdhuidkoeling in drie ziekenhuizen in Nederland. Tijd voor een standaard aanbod van hoofdhuidkoeling?. Oncologica 2005, 22:162-167. [article in Dutch].
31. Nakazawa M., Sakamoto T., Honda M., et al. Scalp hypothermia: a prevention of hair-loss in clinical oncology. Dokkyo J Med Sci 1985, 12:17-24.
32. Keizer-Heldens P. Hoofdhuidkoeling bij haarverlies door chemotherapie. Oncologica 2009, 29-34. [article in Dutch].
33. Kargar M., Sarvestani R.S., Khojasteh H.N., Heidari M.T. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. JAdv Nurs 2011, [epub ahead].
34. Hurk van den C.J.G., Mols F., Vingerhoets A.J., Breed W.P. Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psychooncology 2010, 19:701-709.
35. Hurk van den C.J.G., Breed W.P., Nortier J.W. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 2012, 20:3255-3260.
36. Hurk van den C.J.G., Peerbooms M., van de Poll-Franse L.V., Nortier J.W., Coebergh J.W., Breed W.P. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry. Acta Oncol 2012, 51:497-504.
37. Hurk van den C.J.G., Akker van den -van Marle M.E., Breed W.P.M., Poll van de-Franse L.V., Nortier J.W.R., Coebergh J.W.W. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. JOncol Nurse 2013, [in press].
38. Mallon E., Dawber R.P. Alopecia neoplastica without alopecia: a unique presentation of breast carcinoma scalp metastasis. JAm Acad Dermatol 1994, 31:319-321.
39. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
40. Retsky M.W., Demicheli R., Hrushesky W.J., Baum M., Gukas I.D. Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS 2008, 116:730-741.
41. Demicheli R., Biganzoli E., Boracchi P., Greco M., Retsky M.W. Recurrence dynamics does not depend on the recurrence site. Breast Cancer Res 2008, 10:R83.
42. Goss P.E., Chambers A.F. Does tumour dormancy offer a therapeutic target?. Nat Rev Cancer 2010, 10:871-877.
43. Moore S. Cutaneous metastatic breast cancer. Clin J Oncol Nurs 2002, 6:255-260.
44. Toi M., Yamashiro H., Tsuji W. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer. Breast Cancer 2009, 16:207-218.
45. Kamby C. The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors. Cancer Treat Rev 1990, 17:37-61.